Mumbai: Sun Pharma Laboratories Limited, a wholly owned subsidiary of Sun Pharma, is set to establish a Rs 3,000-crore greenfield formulations manufacturing facility in Madhya Pradesh.The ...

The Delhi High Court has allowed Sun Pharma to manufacture and export semaglutide-based weight-loss drugs.Sun Pharma assured ...

The Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), has directed Sun Pharma ...

A unit of Sun Pharmaceutical Industries plans to invest Rs 3,000 crore on a new manufacturing plant in Madhya Pradesh, according to a regulatory filing.

Sun Pharmaceutical Industries Limited ( ($IN:SUNPHARMA) ) just unveiled an announcement. Sun Pharmaceutical Industries Limited announced that its ...

Sun Pharma, like Dr Reddy's Lab, can't sell semaglutide-based products in India until March 2026 when Novo Nordisk’s patent expires ...

The court, however, permitted Sun Pharma to manufacture and export semaglutide to non-patent countries, extending the same relief it granted Dr. Reddy’s Laboratories in a similar dispute earlier this ...

The fresh plea follows a recent court order allowing Dr. Reddy’s Laboratories (DRL) to continue manufacturing and exporting ...

Latest News, Current Events, Latest Updates, Videos and Photos. December 19, 2025 Read Breaking News on Sun Pharma and Get Complete Insights at India Legal ...

On the heels of an FDA citation and export halt at Sun Pharma’s Mohali, India, manufacturing operations, the U.S. drug regulator is making clear that its demands for corrective actions are ...

The launch comes amid the company’s legal battle with Indian drugmakers, including Dr Reddy’s Laboratories and Sun Pharma, ...

Novo Nordisk Sun Pharma The approval marks a major win for Sun Pharma in its patent dispute with Danish drugmaker Novo Nordisk, the company that manufactures weight loss drug Ozempic ...